IL33132A - Compositions containing quinoxaline derivatives for promoting growth in animals - Google Patents
Compositions containing quinoxaline derivatives for promoting growth in animalsInfo
- Publication number
- IL33132A IL33132A IL33132A IL3313269A IL33132A IL 33132 A IL33132 A IL 33132A IL 33132 A IL33132 A IL 33132A IL 3313269 A IL3313269 A IL 3313269A IL 33132 A IL33132 A IL 33132A
- Authority
- IL
- Israel
- Prior art keywords
- dioxide
- stands
- hydrogen
- quinoxaline
- composition
- Prior art date
Links
- 241001465754 Metazoa Species 0.000 title claims description 39
- 239000000203 mixture Substances 0.000 title claims description 17
- 230000001737 promoting effect Effects 0.000 title claims description 8
- 125000001567 quinoxalinyl group Chemical class N1=C(C=NC2=CC=CC=C12)* 0.000 title 1
- 150000003252 quinoxalines Chemical class 0.000 claims description 31
- 235000005911 diet Nutrition 0.000 claims description 22
- 230000037213 diet Effects 0.000 claims description 22
- 229910052739 hydrogen Inorganic materials 0.000 claims description 21
- 239000001257 hydrogen Substances 0.000 claims description 21
- 238000000034 method Methods 0.000 claims description 18
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 13
- 241000287828 Gallus gallus Species 0.000 claims description 11
- 125000005843 halogen group Chemical group 0.000 claims description 9
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 claims description 9
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 claims description 8
- 150000002431 hydrogen Chemical class 0.000 claims description 8
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims description 7
- -1 methyl radicals Chemical class 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- KZBUYRJDOAKODT-UHFFFAOYSA-N Chlorine Chemical compound ClCl KZBUYRJDOAKODT-UHFFFAOYSA-N 0.000 claims description 3
- 229910052801 chlorine Inorganic materials 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 claims description 3
- 239000005995 Aluminium silicate Substances 0.000 claims description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 2
- 241000237502 Ostreidae Species 0.000 claims description 2
- 229920002472 Starch Polymers 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- IXWIAFSBWGYQOE-UHFFFAOYSA-M aluminum;magnesium;oxygen(2-);silicon(4+);hydroxide;tetrahydrate Chemical compound O.O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Mg+2].[Al+3].[Si+4].[Si+4].[Si+4].[Si+4] IXWIAFSBWGYQOE-UHFFFAOYSA-M 0.000 claims description 2
- 230000000507 anthelmentic effect Effects 0.000 claims description 2
- 239000003242 anti bacterial agent Substances 0.000 claims description 2
- 230000003115 biocidal effect Effects 0.000 claims description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 2
- 239000003224 coccidiostatic agent Substances 0.000 claims description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 2
- 239000008101 lactose Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 235000020636 oyster Nutrition 0.000 claims description 2
- 239000008107 starch Substances 0.000 claims description 2
- 235000019698 starch Nutrition 0.000 claims description 2
- 239000000454 talc Substances 0.000 claims description 2
- 229910052623 talc Inorganic materials 0.000 claims description 2
- WNFQBMMBTAHBOJ-UHFFFAOYSA-N 6-chloro-7-methyl-1,4-dioxidoquinoxaline-1,4-diium Chemical compound ClC=1C=C2[N+](=CC=[N+](C2=CC=1C)[O-])[O-] WNFQBMMBTAHBOJ-UHFFFAOYSA-N 0.000 claims 1
- 235000013330 chicken meat Nutrition 0.000 description 7
- 241000282887 Suidae Species 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- CKIHZSGJPSDCNC-UHFFFAOYSA-N Quindoxin Chemical compound C1=CC=C2N([O-])C=C[N+](=O)C2=C1 CKIHZSGJPSDCNC-UHFFFAOYSA-N 0.000 description 4
- 241000271566 Aves Species 0.000 description 3
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- XSCHRSMBECNVNS-UHFFFAOYSA-N quinoxaline Chemical compound N1=CC=NC2=CC=CC=C21 XSCHRSMBECNVNS-UHFFFAOYSA-N 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- VWRCYAZJKNPEQR-NIEARKAZSA-N (2r,3r)-2,3-dihydroxybutanedioic acid;1-methyl-2-[(e)-2-thiophen-2-ylethenyl]-5,6-dihydro-4h-pyrimidine Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O.CN1CCCN=C1\C=C\C1=CC=CS1 VWRCYAZJKNPEQR-NIEARKAZSA-N 0.000 description 1
- UUKWKUSGGZNXGA-UHFFFAOYSA-N 3,5-dinitrobenzamide Chemical compound NC(=O)C1=CC([N+]([O-])=O)=CC([N+]([O-])=O)=C1 UUKWKUSGGZNXGA-UHFFFAOYSA-N 0.000 description 1
- 108010001478 Bacitracin Proteins 0.000 description 1
- ZDPIZLCVJAAHHR-UHFFFAOYSA-N Clopidol Chemical compound CC1=NC(C)=C(Cl)C(O)=C1Cl ZDPIZLCVJAAHHR-UHFFFAOYSA-N 0.000 description 1
- ZEFNOZRLAWVAQF-UHFFFAOYSA-N Dinitolmide Chemical compound CC1=C(C(N)=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O ZEFNOZRLAWVAQF-UHFFFAOYSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 description 1
- NNOPDLNHPOLRRE-UHFFFAOYSA-N Nequinate Chemical compound CCCCC1=CC(C(C(C(=O)OC)=CN2)=O)=C2C=C1OCC1=CC=CC=C1 NNOPDLNHPOLRRE-UHFFFAOYSA-N 0.000 description 1
- 239000004104 Oleandomycin Substances 0.000 description 1
- RZPAKFUAFGMUPI-UHFFFAOYSA-N Oleandomycin Natural products O1C(C)C(O)C(OC)CC1OC1C(C)C(=O)OC(C)C(C)C(O)C(C)C(=O)C2(OC2)CC(C)C(OC2C(C(CC(C)O2)N(C)C)O)C1C RZPAKFUAFGMUPI-UHFFFAOYSA-N 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- 239000004188 Virginiamycin Substances 0.000 description 1
- 108010080702 Virginiamycin Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- LCTXBFGHZLGBNU-UHFFFAOYSA-M amprolium Chemical compound [Cl-].NC1=NC(CCC)=NC=C1C[N+]1=CC=CC=C1C LCTXBFGHZLGBNU-UHFFFAOYSA-M 0.000 description 1
- 229960003683 amprolium Drugs 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 229960003071 bacitracin Drugs 0.000 description 1
- 229930184125 bacitracin Natural products 0.000 description 1
- CLKOFPXJLQSYAH-ABRJDSQDSA-N bacitracin A Chemical compound C1SC([C@@H](N)[C@@H](C)CC)=N[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]1C(=O)N[C@H](CCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2N=CNC=2)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)NCCCC1 CLKOFPXJLQSYAH-ABRJDSQDSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- JHAYEQICABJSTP-UHFFFAOYSA-N decoquinate Chemical compound N1C=C(C(=O)OCC)C(=O)C2=C1C=C(OCC)C(OCCCCCCCCCC)=C2 JHAYEQICABJSTP-UHFFFAOYSA-N 0.000 description 1
- 229960001878 decoquinate Drugs 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 229960001614 levamisole Drugs 0.000 description 1
- 235000009973 maize Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- RZPAKFUAFGMUPI-KGIGTXTPSA-N oleandomycin Chemical compound O1[C@@H](C)[C@H](O)[C@@H](OC)C[C@@H]1O[C@@H]1[C@@H](C)C(=O)O[C@H](C)[C@H](C)[C@H](O)[C@@H](C)C(=O)[C@]2(OC2)C[C@H](C)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C RZPAKFUAFGMUPI-KGIGTXTPSA-N 0.000 description 1
- 235000019367 oleandomycin Nutrition 0.000 description 1
- 229960002351 oleandomycin Drugs 0.000 description 1
- 229960005141 piperazine Drugs 0.000 description 1
- 229960005134 pyrantel Drugs 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 229960003842 virginiamycin Drugs 0.000 description 1
- 235000019373 virginiamycin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Description
COMPOSITIONS CONTAINING QUINOXALINE DEMVATIVES FOR PROMOTING GROWTH IN ANIMALS o»»n » p3 >n > D'Diian i» »e i3' w nn in o'^'san o'-pwan This invention relates to a method of promoting the growth of domestic animals, that is it relates to a method of accelerating the rate of growth of domestic animals over and above the rate of growth normally achieved by such animals when fed on a nutritionally-balanced diet · Aocording to the invention there is provided a method of promoting the growth of domestio animals which comprises feeding such animals on a nutritionally-balanced diet which additionally contains a quinoxaline derivative of the formula:- 0 0 wherein, when R and R stand for hydrogen, R stands for a hydrogen or halogen atom, or a methyl radioal, and R^ stands for hydrogen or a 1 2 3 methyl radical; or when R and R stand for methyl radioals, then R stands for a halogen atom and R^ stands for hydrogen.
A preferred value for R^ when it stands for a halogen atom is a ohlorine or bromine atom.
The method of the invention is applicable to all domestio animals, for example poultry, pigs, sheep and oattle.
The nutritionally-balanced diet should contain from 0.0001$ w/w (lg. per metric ton) to 0.025$ w/w (250g. per metric ton) of a quinoxaline derivative as defined above, or from 0.0001$ w/w (lg. per metric ton) to 0.0025$ w/w (25g« per metric ton) of the preferred quinoxaline derivative. The animals may "be fed on such a supplemented diet for substantially the whole of their growing period, or they may be fed on the diet for only a part, preferably the earlier part, of their growing period, in order to achieve the desired increase in the rate of growth of the animals. Suoh an increase in the rate of growth of the animals enables the animals to be brought to a desired market weight in a shorter growing period than previously employed, or it enables heavier animals to be produced at the end of the previously employed growing period. In addition, it has been found that the method of the invention leads to improved food conversion ratios, that is animals fed on a diet containing a quinoxaline derivative as defined above are found to attain a given weight after the consumption of less food than animals fed on a diet not containing such a quinoxaline derivative.
Specific quinoxaline derivatives whioh may be used in the method of the invention are, for example, quinoxaline-l,4-dioxide, 6-methylquinoxaline-l,4-dioxide, 6-chloro-2 ,3-dimethylquinoxaline-l,4-dioxide, 6-bromo-2 ,3-dimethylquinoxaline-l,4-dioxide, 6,7-dimethyl-quinoxaline-l,4-dioxide and 6-chloro-7-methylquinoxaline-l,4-dioxide, and of these, the preferred oompound is quinoxaline-l,4-dioxide itself.
In order to oarry out the method of the invention, a quinoxaline derivative as defined above may be fed to domestic animals in the form of a supplemented foodstuff f and such a foodstuff may be prepared by diluting a concentrated pre-mix.
According to a further feature of the invention there is provided an animal foodstuff composition which comprises a quinoxaline derivative of the formulai- 0 wherein, when R and R stand for hydrogen, R stands for a hydrogen or halogen atom, or a methyl radical, and R^" stands for hydrogen or a 1 2 3 methyl radical; or when R and R stand for methyl radicals, then R stands for a bromine atom and R^ stands for hydrogen, together with a substantially solid edible carrier therefor.
A preferred value for R^ when it stands for a halogen atom 1 2 when R and R stand for hydrogen, is a chlorine or bromine atom.
As indicated above, the composition may be in the form of a concentrated pre-mix suitable for dilution with a nutritionally-balanced foodstuff to provide a supplemented animal foodstuff,- or it may be in the form of an animal foodstuff suitable for direct feeding to domestic animals to increase their rate of growth.
A suitable pre-mix is, for example, a mixture of a quinoxaline derivative defined immediately above with an inert edible carrier, for example kaolin, talc, calcium carbonate, fuller's earth, attapulgus clay, ground oyster shells v starch or lactose, or vdth a nutritionally-balanced edible carrier, for example a standard broiler chicken diet of ground grain and grain by-products, animal protein supplemented by vitamins and minerals, or other conventional animal foodstuff.
Such a pre-mix may contain from 0.2$ w/w to °$ w/w °f quinoxaline derivative or from 0.2$ w/w to 5$ w/w of the preferred quinoxaline derivative, and may be diluted with a nutri ionally-balanced foodstuff to produce an animal foodstuff containing from 0.0001$ w/w to 0.025$ w/w of quinoxaline derivative or from 0.0001$ w/w to 0.0025$ w/w of the preferred quinoxaline derivative. In diluting the above pre-mixes, it is convenient to incorporate 00g» °f pre-mix in 1 metric ton of animal foodstuff.
The animal foodstuff intended for direct feeding to domestic animals j and the pre-mixes, may also oontain other compounds of known veterinary utility, for example an anthelmintic, for example tetramisole, pyrantel tartrate, thiabendazole or piperazine, a coccidiostat , for example methyl benzoquate, meticlorpindol, 3,5-dinitro-o-toluamide, 3,5-dinitrobenzamide, amprolium or decoquinate, or an antibiotic, for example bacitracin, oleandomycin or virginiamycin.
Aooording to a further feature of the invention there is provided a process for the manufacture of an animal foodstuff composition as hereinbefore defined which comprises uniformly mixing quinoxaline derivative of the formula:- 0 wherein, when stands for a hydrogen or halogen atom, or a methyl radical, and R^" stands for hydrogen or a 1 2 3 methyl radical; or when R and R stand for methyl radicals, then R stands for a bromine atom and R^ stands for hydrogen, together with a substantially solid edible carrier therefor.
The growth promoting properties of the quinoxaline derivatives defined above as being suitable for feeding to domestic animals in accord with the method of the invention, and of compositions containing those quinoxaline derivatives, have been demonstrated by feeding groups of domestic animals on a diet containing the quinoxaline derivative for a standard time, and then comparing the increase in weight of those animals with the increase in weight of a control group of animals fed on the same basic diet but not containing such a quinoxaline derivative.
The invention is illustrated but not limited by the following Examples Example 1 Pre-mixes suitable for dilution with an animal foodstuff may be obtained by incorporating 5 i 10, 25 , 5° °r lOOg. of quinoxaline-1,4-dioxide in a standard broiler chicken diet comprising ground maize and fishmeal, with added lysine , methionine , vitamins and minerals , so that the final weight of pre-mix is 500g.
Other pre-mixes may be obtained by replaoing the quinoxaline- 1,4-dioxide by 6-methylquinoxaline-l,4-dioxide , 6-bromo-2 ,3-dimethyl-quinoxaline-l,4-dioxide , 6,7-diniethylquinoxaline-l,4-dioxide or 6-chloro-7-methylquinoxaline-l,4-dioxide .
Example 2 An animal foodstuff intended for direct feeding to poultry may be obtained by intimately mixing 500g. of a pre-mix obtained as described in Example 1 with 1 metric ton ( 1000kg. ) of standard broiler chicken diet .
Example 3 Groups of 60 7-day-old chickens were weighed and kept in oages in which 10 chickens were present in each cage . One group of chickens was fed for 6 days on a basic nutritionally-balanced diet containing no compound known to possess growth promoting properties , and fourteen other groups were fed for 6 days on the same basio diet but containing amounts of a quinoxaline derivative varying from 0,01 w/w to 0,0005 w/w. At the end of the 6 days , all the chickens were weighed, and the increase in weight of each group was recorded, A compound showing growth promotion properties caused the birds in the treated group to show a greater increase in weight than the increase in weight shown by the oontrol group. The difference between these increases in weight , expressed as a percentage of the increase in weight of the control group, was considered to be significant if it was equal to or greater than 11$ more than the increase in weight of the control group.
The following results were obtained with test quinoxaline derivatives 0 $ of test io difference compound in the between increases food in the weights R1 R2 R3 R4 of the treated and control groups H H H H 0.01 + 34.6 0.005 + 33.0 0.0025 + 20.9 0.001 + 18.2 0.0005 + 19.0 H H Me H 0.01 + 34.6 Mo Me CI H 0.01 + 25.2 Me Me Br H 0.01 + 33.8 H H Me Me 0.01 + 42.5 H H CI Me 0.01 + 41.3 Example 4 In an essentially similar procedure to that described in Example 3, a group of 360 1-day-old chickens, kept in pens each containing 60 chickens, was fed on a diet containing quinoxaline-1,4-dioxide and the rate of growth over 8 weeks observed relative to a similar control group of 360 chickens. The following, result was obtained at the end of 8 weeks. Mean weight of birds in the control group - 1.60kg. Mean weight of birds fed on a diet oontaining 0.001$ w/w of quinoxaline-l,4-dioxide - 1.82kg. Ratio of food eaten/weight of bird in the control group - 2.18. Ratio of food eaten/weight of bird in the treated group - 2.02.
Example 5 In a test on pigs, in which each group contained 6 pigs, the folloviing results were obtained after 7 weeks feeding.
Hogs: mean increase in weight per pig of the pigs in the control group - 21,8kg. mean increase in weight per pig of the pigs in the group fed on a diet containing 0.001$ w/w of quinoxaline-l,4-dioxide - 24.2kg.
Gilts: mean increase in weight per pig in the control group - 22.9ig. mean increase in weight per pig in the group fed on a diet containing 0.001$ w/w of quinoxaline- 1,4-dioxide - 25»lkg.
Claims (18)
1. 2 3 methyl radical f or when R and R stand for methyl radicals, then R Btands for a halogen atom and ^ stands for hydrogen.
2. A method as claimed in claim 1 wherein R^ stands for a chlorine or bromine atom,
3. A method as claimed in claim 1 wherein the quinoxaline derivative is quinoxaline-l,4-dioxide,
4. · A method as olaimed in claim 1 wherein the quinoxaline derivative 'is 6-methylquinoxaline-l,4-dioxide, 6-chloro-2 , 3-dimethyl-quinoxaline-1 ,4-d oxide , 6-bromo-2 , 3-dimethylquinoxaline-l ,4-dioxide , 6 , 7-dimethylquinoxaline-l,4-dioxide or 6-chloro-7-methylquinoxaline-1 ,4-dioxide o
5. · A method as claimed in any preceding claim wherein the nutritionally-balanced diet contains from 0.0001$ w/w to 0.025$ w/w of the quinoxaline derivative.
6. A method as claimed in claim 3 wherein the nutritionally-balanoed diet contains from 0.0001$ w/w to 0.0025$ w/w of the quinoxaline derivative.
7. An animal foodstuff composition which comprises a quinoxaline derivative of the formula:- wherein, when R and R stand for hydrogen, R stands for a hydrogen or halogen atom, or a methyl radical, and R^ stands for hydrogen or a methyl radical} or when R 1 and R2 stand for methyl radicals, then R 3 stands for a bromine atom and R^ stands for hydrogen, together with a substantially solid edible carrier therefor. 1 2
8. A composition as olaimed in claim 7 wherein when R and R stand for hydrogen, R^ stands for a chlorine or bromine atom.
9. A composition as claimed in claim 7 wherein the quinoxaline derivative is quinoxaline-l,4*-dioxide.
10. A composition as claimed in claim 7 wherein the quinoxaline derivative is 6-methylquinoxaline-l,4-dioxide, 6-bromo-2 ,3-dimethyl-quinoxaline-l,4-dioxide, 6,7-dimethylquinoxaline-l,4-dioxide or 6- ' ch 1oro-7-methylq inoxaline- 1 , 4-dioxide.
11. , A composition as claimed in any of claims 7 to 10, wherein the edible carrier is an inert edible carrier, for example kaolin, talc, calcium carbonate, fuller's earth, attapulgus clay, ground oyster shells, starch or lactose.
12. , A composition as claimed in any of claims 7 to 10, wherein the edible carrier is a nutritionally-balanced edible carrier,, for example a standard broiler chicken diet.
13. · A composition as claimed in any of claims 7 to 12, which is in the form of a concentrated pre-mix and contains from 0.2$ w/w to 50$ w/w of quinoxaline derivative.
14. A composition as claimed in any of claims 7 to 10 and 12 which is in the form of an animal foodstuff intended for direct feeding and contains from 0.0001$ w/w to 0.025$ w/w of quinoxaline derivative,,
15. A composition as claimed in claim 13 or 14 which additionally contains other compounds of known veterinary utility, for example an anthelmintic, a coccidiostat , or an antibiotic.
16. A process for the manufacture of an animal foodstuff as claimed in claim 7 which comprises uniformly mixing a quinoxaline derivative as defined in claim 7 together with a substantially solid edible carrier therefor.
17. A method of promoting the growth of domestic animals as claimed in claim 1, substantially as described in Example 3 or 4·
18. l8. A animal foodstuff composition as claimed in claim 7 substantially as described in Example 1 or 2.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB51473/68A GB1223720A (en) | 1968-10-30 | 1968-10-30 | Growth promotion |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL33132A0 IL33132A0 (en) | 1969-12-31 |
| IL33132A true IL33132A (en) | 1972-04-27 |
Family
ID=10460163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL33132A IL33132A (en) | 1968-10-30 | 1969-10-07 | Compositions containing quinoxaline derivatives for promoting growth in animals |
Country Status (13)
| Country | Link |
|---|---|
| JP (1) | JPS49115870A (en) |
| BE (1) | BE740989A (en) |
| CY (1) | CY670A (en) |
| DE (1) | DE1954226C3 (en) |
| ES (1) | ES372978A1 (en) |
| FR (1) | FR2021953A1 (en) |
| GB (1) | GB1223720A (en) |
| HU (1) | HU162811B (en) |
| IE (1) | IE33324B1 (en) |
| IL (1) | IL33132A (en) |
| MY (1) | MY7300224A (en) |
| NL (1) | NL6915635A (en) |
| ZA (1) | ZA696675B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4012512A (en) * | 1972-09-05 | 1977-03-15 | Ciba-Geigy Corporation | Animal feeds containing quinoxaline-di-n-oxide derivatives |
| SU890961A3 (en) | 1976-01-20 | 1981-12-15 | Циба-Гейги Аг (Фирма) | Growth stimulating agent for animals |
| US4128642A (en) * | 1976-12-20 | 1978-12-05 | International Minerals & Chemical Corp. | Method of promoting growth and improving feed efficiency of animals |
| EP0002893A1 (en) * | 1977-12-22 | 1979-07-11 | Imperial Chemical Industries Plc | Growth promotion means for ruminant animals and method for its production |
| US4629790A (en) * | 1980-08-07 | 1986-12-16 | Angus Chemical Company | Quinoxaline adducts useful as anthelmintics |
| DE3230273A1 (en) * | 1982-08-14 | 1984-02-16 | Bayer Ag, 5090 Leverkusen | LIGHT-STABILIZED CHINOXALINE DI-N-OXIDES |
| DE19854559A1 (en) * | 1998-11-26 | 2000-06-15 | Joern Gmbh | Automotive steering column push-pull dampener having piston and a cylinder housing separated by a spring with an elastic component taking up the vibrations |
-
1968
- 1968-10-30 GB GB51473/68A patent/GB1223720A/en not_active Expired
-
1969
- 1969-09-22 IE IE1323/69A patent/IE33324B1/en unknown
- 1969-09-22 ZA ZA696675*A patent/ZA696675B/en unknown
- 1969-10-07 IL IL33132A patent/IL33132A/en unknown
- 1969-10-15 NL NL6915635A patent/NL6915635A/xx unknown
- 1969-10-28 DE DE1954226A patent/DE1954226C3/en not_active Expired
- 1969-10-29 BE BE740989D patent/BE740989A/xx unknown
- 1969-10-29 ES ES372978A patent/ES372978A1/en not_active Expired
- 1969-10-30 FR FR6937378A patent/FR2021953A1/fr not_active Withdrawn
- 1969-10-30 HU HUIE372A patent/HU162811B/hu unknown
-
1971
- 1971-08-20 JP JP46063541A patent/JPS49115870A/ja active Pending
-
1973
- 1973-02-08 CY CY67073A patent/CY670A/en unknown
- 1973-12-30 MY MY224/73A patent/MY7300224A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MY7300224A (en) | 1973-12-31 |
| IE33324L (en) | 1970-04-30 |
| GB1223720A (en) | 1971-03-03 |
| IL33132A0 (en) | 1969-12-31 |
| DE1954226A1 (en) | 1970-07-09 |
| ZA696675B (en) | 1971-04-28 |
| HU162811B (en) | 1973-04-28 |
| JPS49115870A (en) | 1974-11-06 |
| DE1954226C3 (en) | 1975-07-03 |
| IE33324B1 (en) | 1974-05-15 |
| CY670A (en) | 1973-02-08 |
| BE740989A (en) | 1970-04-29 |
| ES372978A1 (en) | 1971-11-16 |
| DE1954226B2 (en) | 1974-11-14 |
| NL6915635A (en) | 1970-05-04 |
| FR2021953A1 (en) | 1970-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4711897A (en) | Animal feed methods and compositions using cysteamine | |
| Donaldson et al. | Studies on energy levels in poultry rations: 3. Effect of calorie-protein ratio of the ration on growth, nutrient utilization and body composition of poults | |
| IL33132A (en) | Compositions containing quinoxaline derivatives for promoting growth in animals | |
| Fisher et al. | Metabolisable energy determinations using chicks and turkeys | |
| KR910002420B1 (en) | Feed composition for promoting the growth of animals | |
| RU2573960C2 (en) | Feed product for broiler chickens | |
| US4087554A (en) | Method for improving growth rate and feed efficiency | |
| Kennard et al. | Built-up floor litter as a source of dietary factors essential for the growth of chickens | |
| US3627883A (en) | Antibiotic x206 for treating coccidiosis | |
| US3914428A (en) | Method of using 2-arylimino-1,3-dithietane compounds as growth promotants | |
| US3279923A (en) | Growth-promoting and yield-increasing feedstuffs which contain the antibiotic moenomycin | |
| US3051573A (en) | Feed containing carboxymethoxylamine | |
| NL8401217A (en) | GROWTH-PROMOTING DRY FEED AND FEED ADDITIVES, AND METHOD FOR PREPARING IT. | |
| US3036917A (en) | Feeding ruminants 9alpha-fluoro-16alpha-methylprednisolone | |
| Atkinson et al. | Nutritive value of meat meals III.—value of meat meals as supplements to a cereal basal diet: Limiting amino acids in these diets | |
| Menge et al. | Effect of supplemental DL-methionine and varying protein levels on growth and feed requirements of broiler chickens | |
| US3284210A (en) | Feed compositions containing n-substituted aminooxyacetic acid compounds and methods | |
| IE42655B1 (en) | Methods using, and compositions containing, quinone derivatives, for use in animal husbandry | |
| GB1564187A (en) | Composition and method for promoting animal nutrition | |
| Milošević et al. | Nutritive value of corn meal in nutrition of fattening chickens | |
| JPS60208988A (en) | Monosilylated aminophenylethylamine derivative, manufacture and use | |
| US2776889A (en) | Fortified animal feeds | |
| PL115472B1 (en) | Fodder appropriated for pigs not being afflicted with dysentery | |
| US3373035A (en) | Estrogenic compounds and animal growth promoters | |
| US3373036A (en) | Estrogenic compounds and animal growth promoters |